Verition Fund Management LLC Acumen Pharmaceuticals, Inc. Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 19,445 shares of ABOS stock, worth $24,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,445Holding current value
$24,500% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ABOS
# of Institutions
81Shares Held
40.6MCall Options Held
28.6KPut Options Held
76.4K-
Ra Capital Management, L.P. Boston, MA14.9MShares$18.8 Million0.42% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$4.31 Million2.23% of portfolio
-
Franklin Resources Inc San Mateo, CA3.27MShares$4.12 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$2.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.45 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $51M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...